Latest filing published 19 Apr 2021 for FIVE PRIME THERAPEUTICS INC, €1.1M.
David White discloses dealings in 2 companies, chiefly Five Prime Therapeutics Inc and Chiron Corp. Between 19 April 2006 and 16 April 2021, the trades on record add up to 9 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 19 April 2021 came the latest disclosure, a transaction for €1.1M in Five Prime Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations